Cormorant Asset Management, LP sold $942k of EYPT
other at EyePoint, Inc.. 60,000 shares at an average of $15.70, traded Dec 4, 2025, filed Dec 8, 2025.
Score components
- +8RoleOther
- +24Trade size$942k at market
- 0Share of holdings soldSold 0.7% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000929638-25-004521, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 4, 2025 | SOpen-market sale Common Stockindirect: See Footnotes | -60,000 | $15.70 | $942k | 8,265,000 | Dec 8, 2025 |
Related signals
Other insiders at EyePoint, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 29Weak | EYPTbuy EyePoint, Inc. | Jay S. Duker President and CEO | $20k 1,500 shares | +2% | |
| 6Weak | EyePoint, Inc. | Ramiro Ribeiro Chief Medical Officer | $44k 2,438 shares | -100% | |
| 6Weak | EyePoint, Inc. | Ramiro Ribeiro Chief Medical Officer | $37k 2,437 shares | -100% | |
| 21Weak | EyePoint, Inc. | Ramiro Ribeiro Chief Medical Officer | $727k 42,544 shares | -100% | |
| 14Weak | EyePoint, Inc. | Nancy Lurker director | $140k 9,300 shares | -4% | |
| 3Weak | EyePoint, Inc. | Nancy Lurker director | $10k 700 shares | -0% | |
| 20Weak | EyePoint, Inc. | Ramiro Ribeiro Chief Medical Officer | $32k 2,722 shares | -100% | |
| 33Weak | EYPTbuy EyePoint, Inc. | Karen L. Zaderej director | $59k 10,000 shares | +38% | |
| 32Weak | EYPTbuy EyePoint, Inc. | Karen L. Zaderej director | $54k 10,000 shares | +61% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.